Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nausea × casopitant × Clear all

Phase

Phase 3 3 Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Nausea 1

Interventions

Aprepitant 11 Palonosetron 8 Dexamethasone 7 Ondansetron 5 Olanzapine 5 netupitant 2 Fluorouracil 2 Calcium Dobesilate 2 yangzheng xiaoji 1 rolapitant 1 ramosetron 1 niraparib 1 netupitant, palosentron drug combination 1 nabiximols 1 isatuximab 1 ginger extract 1 fosaprepitant 1 dolasetron 1 casopitant 1 Tropisetron 1 Therapeutics 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Octreotide 1 Midazolam 1 Leucovorin 1 Lactose 1 L 758298 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

GlaxoSmithKline

Phase 2 Completed

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡